Aequus Pharmaceuticals Company Description

Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada.

The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma.

It also develops REV-0100 for the treatment of stargardt disease that is in pre-clinical trial. The company has a strategic collaboration with reVision for the development of a therapy for stargardt disease.

Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Aequus Pharmaceuticals Inc.

Country	Canada
Founded	2013
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	12
CEO	Douglas Janzen

Contact Details

Address: 200 Granville Street Vancouver, British Columbia V6C 1S4 Canada
Phone	604 336 7906
Website	aequuspharma.ca

Stock Details

Ticker Symbol	AQS
Exchange	TSX Venture Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA0076361033
SIC Code	2834

Key Executives

Name	Position
Douglas Glen Janzen	Chairman, Chief Executive Officer and President